Bexil Corporation Announces 2008 Financial Results


MESSAGE FROM BEXIL

	Letter from the President

	Overview

COMMUNICATIONS

	All Press Releases

	Shareholder Reports and Proxy Statements

	Rule 15c2-11 Information

	Investor Conference Calls

GOVERNANCE

	Board of Directors

	Executives

	Other Governance Info

CONTACT US

	Contact Bexil

	Contact Transfer Agent

	Press Releases

May 12, 2009 - Bexil Corporation (Ticker Symbol: BXLC) today reported its financial results for the year ended December 31, 2008.

Bexil recorded net income of $261,388 or $0.29 per share on a diluted basis for the year ended December 31, 2008 compared to net income of $257,795 or $0.28 per share on a diluted basis for the year ended December 31, 2007.

The Company’s book value per share at December 31, 2008 (883,592 shares issued and outstanding) was $43.67, as compared to $43.53 at December 31, 2007. At December 31, 2008, we had positive working capital of $38,464,347, total assets of $38,738,736, no long term debt, and shareholders' equity of $38,583,085. The Company’s primary source of income since the sale of its fifty percent interest in York Insurance Services Group, Inc. (“York”) in April 2006 has been from interest and dividends earned from U.S. Treasury securities and money market funds.

The Company’s 2008 Annual Report, including audited financial statements, is available on www.bexil.com.

Business Overview
Since the sale of the York shares, we have been operating to acquire and/or develop one or more businesses. There are no limits on the types of businesses or fields in which we may devote the Company’s assets. We have not agreed to acquire any business as of the date of this press release. We have no plans to dissolve and liquidate the Company.

Our acquisition parameters for a public company and private business are:

A proven track record with demonstrated earning power.
A seasoned business with solid customer relations.
Good return on equity, with little or no debt.
Solid management. Audited financials required.
Particularly interested in a “spin-off” from a larger company.

We generally are not interested in acquiring (but we may develop) start-ups, turnarounds, or high tech. We will sign a confidentiality agreement and will protect a broker’s sell agreement. If the seller quotes a price, we will respond promptly.

About Bexil Corporation
Bexil is a holding company. To learn more about Bexil Corporation, including Rule 15c2-11information, please visit www.bexil.com. Approximately 25% of Bexil's shares are owned by Winmill & Co. Incorporated (WNMLA), which is engaged through subsidiaries in stock market and gold investing through its investment management of equity and gold mutual funds.

This release contains certain “forward looking statements” made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties and other factors, many of which are beyond the control of Bexil Corporation, which may cause the Company’s actual results to be materially different from those expressed or implied by such statements. The forward looking statements made herein are only made as of the date of this release, and the Company undertakes no obligation to publicly update such forward looking statements to reflect subsequent events or circumstances.

The Company views book value per share, a non-GAAP financial measure, as an important indicator of financial performance. Presented in conjunction with other financial information, the combined presentation can enhance an investor's understanding of the Company's underlying financial condition and results from operations. The definition of book value as presented in this press release is shareholders' equity divided by currently issued and outstanding shares.

Contact:            Thomas O’Malley
                        Chief Financial Officer
                        1-212-785-0400, ext. 267
                                tomalley@bexil.com
                        www.bexil.com

Press Release Links

11 Hanover Square, New York, NY 10005 Tel: 1-212-785-0400 Fax: 1-212-363-1101
Home | Contact
© Bexil Corporation || info@bexil.com || www.Bexil.com